MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | - | - | ₹1.45 Cr | ₹1.45 Cr | ₹20 Cr |
What is the latest Contingent Liabilities ratio of MARKSANS PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2025 | - |
Mar2024 | - |
Mar2023 | ₹1.45 Cr |
Mar2022 | ₹1.45 Cr |
Mar2021 | ₹20 Cr |
How is Contingent Liabilities of MARKSANS PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | - | 0 | |
Mar2024 | - | -100.00 | |
Mar2023 | ₹1.45 Cr | 0.00 | |
Mar2022 | ₹1.45 Cr | -92.68 | |
Mar2021 | ₹20 Cr | - |
Compare Contingent Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹9,768.7 Cr | -5.4% | -14.7% | 17.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,478.0 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,845.0 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
CIPLA | ₹120,121.0 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -5.4% |
-14.7% |
17.4% |
SENSEX | -1.2% |
-3.5% |
-0.5% |
You may also like the below Video Courses